TickerFacts.

Edwards Lifesciences Corp (EW): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.08B
Year ended 2025-12-31
$1.09B
Trailing 12 months to 2026-06-30
+8.6%
3-year compound annual growth
2008-12-31: $139.20M2009-12-31: $175.50M2010-12-31: $204.40M2011-12-31: $246.30M2012-12-31: $291.30M2013-12-31: $323.00M2014-12-31: $346.50M2015-12-31: $382.90M2016-12-31: $442.20M2017-12-31: $552.60M2018-12-31: $622.20M2019-12-31: $752.70M2020-12-31: $760.70M2021-12-31: $903.10M2022-12-31: $843.60M2023-12-31: $962.90M2024-12-31: $1.05B2025-12-31: $1.08B$1.08B
2008-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$1.08B+2.5%2026-02-25, From 2025-01-01
2024-12-31$1.05B+9.4%2026-02-25, From 2024-01-01
2023-12-31$962.90M+14.1%2026-02-25, From 2023-01-01
2022-12-31$843.60Mn/c2025-02-28, From 2022-01-01
2021-12-31$903.10M+18.7%2024-02-12, From 2021-01-01
2020-12-31$760.70M+1.1%2023-02-13, From 2020-01-01
2019-12-31$752.70M+21.0%2022-02-14, From 2019-01-01
2018-12-31$622.20M+12.6%2021-02-12, From 2018-01-01
2017-12-31$552.60M+25.0%2020-02-14, From 2017-01-01
2016-12-31$442.20M+15.5%2019-02-15, From 2016-01-01
2015-12-31$382.90M+10.5%2018-02-16, From 2015-01-01
2014-12-31$346.50M+7.3%2017-02-17, From 2014-01-01
2013-12-31$323.00M+10.9%2016-02-19, From 2013-01-01
2012-12-31$291.30M+18.3%2015-02-20, From 2012-01-01
2011-12-31$246.30M+20.5%2014-02-28, From 2011-01-01
2010-12-31$204.40M+16.5%2013-02-28, From 2010-01-01
2009-12-31$175.50M+26.1%2012-02-27, From 2009-01-01
2008-12-31$139.20Mn/a2011-02-28, From 2008-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Edwards Lifesciences Corp (EW)2025-12-31$1.08B+2.5%
Steris PLC (STE)2026-03-31$112.90M+4.9%
Zimmer Biomet Holdings, Inc. (ZBH)2025-12-31$458.50M+4.8%
Align Technology Inc (ALGN)2025-12-31$369.91M+1.6%
Intuitive Surgical Inc (ISRG)2025-12-31$1.31B+14.5%
Enovis Corp (ENOV)2025-12-31$120.33M+31.8%
MSA Safety Inc (MSA)2025-12-31$65.34M-1.8%
Cadre Holdings, Inc. (CDRE)2025-12-31$11.40M+36.0%
Inogen Inc (INGN)2025-12-31$19.40M-10.2%

Compare EW, STE, ZBH, ALGN side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗